1 | subsequently | 4,727 |
2 | ultimately | 1,755 |
3 | eventually | 1,246 |
4 | secondarily | 260 |
5 | hopefully | 239 |
6 | ankaflavin | 12 |
7 | aph-4 | 8 |
8 | caldesmon | 7 |
9 | multivariately | 7 |
10 | parallelly | 7 |
11 | schematically | 7 |
12 | thereupon | 7 |
13 | viscolin | 7 |
14 | biatain-ag | 6 |
15 | administratively | 5 |
16 | kitao | 5 |
17 | someday | 5 |
18 | undercorrected | 5 |
19 | wip1 | 5 |
20 | bohu-tusyo-san | 4 |
21 | gfp-cts1 | 4 |
22 | higenamine | 4 |
23 | irrationally | 4 |
24 | kep10 | 4 |
25 | laughed | 4 |
26 | lg100268 | 4 |
27 | purob | 4 |
28 | veronicaefolia | 4 |
29 | brooks-gunn | 3 |
30 | cbhiix305 | 3 |
31 | il‑8 | 3 |
32 | mex-5 | 3 |
33 | mussaenoside | 3 |
34 | pcp-1 | 3 |
35 | stenocardia | 3 |
36 | 10,242 | 2 |
37 | 2-naphthalenol | 2 |
38 | 5-pyrimidinols | 2 |
39 | 58±7 | 2 |
40 | al-ivm2 | 2 |
41 | bp230 | 2 |
42 | chrysoeriol-7-o-d-glucoside | 2 |
43 | coccolithophores | 2 |
44 | dex-treatment | 2 |
45 | dimethylcrocetin | 2 |
46 | echolucencies | 2 |
47 | eyeshield | 2 |
48 | finesrt | 2 |
49 | iiime | 2 |
50 | imprecision.we | 2 |
51 | karyoplasts | 2 |
52 | lagakos | 2 |
53 | milstein | 2 |
54 | nde2 | 2 |
55 | onthe | 2 |
56 | p.ala1610ser | 2 |
57 | paclitaxel-doxorubicin-cisplatin | 2 |
58 | pbrm-1/baf180 | 2 |
59 | pustulan | 2 |
60 | r226q | 2 |
61 | rf-coils | 2 |
62 | rtms-tdcs | 2 |
63 | ser65→pro | 2 |
64 | shame-reduction | 2 |
65 | vinylarenes | 2 |
66 | ws/mongolia/1/09 | 2 |
67 | x12b | 2 |
68 | yedz | 2 |
69 | 1,4-diols | 1 |
70 | 1,8-diaminooctane | 1 |
71 | 1.49±0.59 | 1 |
72 | 115/261 | 1 |
73 | 13,339 | 1 |
74 | 14,677 | 1 |
75 | 15,740 | 1 |
76 | 4,4'-dichlorodiphenyltrichloroethane | 1 |
77 | 4,4-dimethylproline | 1 |
78 | 4,847 | 1 |
79 | 41,514 | 1 |
80 | 48/87 | 1 |
81 | 56,603 | 1 |
82 | abciximam | 1 |
83 | ag-zp | 1 |
84 | ammionia | 1 |
85 | angiocholitis | 1 |
86 | c-coils | 1 |
87 | canalis | 1 |
88 | capabilities.measurements | 1 |
89 | carnidazol | 1 |
90 | caspsase-9 | 1 |
91 | celleagues | 1 |
92 | cluster-analyses | 1 |
93 | co-publication | 1 |
94 | communities.we | 1 |
95 | cpeb4 | 1 |
96 | d-methyl | 1 |
97 | dcers | 1 |
98 | discariosi | 1 |
99 | donadio | 1 |
100 | dwarves | 1 |
101 | eligible.we | 1 |
102 | exretion | 1 |
103 | felony-level | 1 |
104 | fesses | 1 |
105 | flexi | 1 |
106 | ga₂o₃ | 1 |
107 | gel² | 1 |
108 | guenther | 1 |
109 | habituations | 1 |
110 | haemorperitoneum | 1 |
111 | herbal/botanical/supplements | 1 |
112 | hit-to | 1 |
113 | hydrae | 1 |
114 | hydroxycholoroquine | 1 |
115 | hypoxia-only | 1 |
116 | incorporateself-management | 1 |
117 | laser-curettage/srp/laser-sealing | 1 |
118 | loss-framing | 1 |
119 | luminesce | 1 |
120 | lvht-patients | 1 |
121 | maleinization | 1 |
122 | mitogen/s | 1 |
123 | mokhada | 1 |
124 | mssa-negative | 1 |
125 | málek | 1 |
126 | nano-phytoplankton | 1 |
127 | o-glycanase | 1 |
128 | owner/manager | 1 |
129 | p38-nf-kb-sasp | 1 |
130 | pge-3521917-were | 1 |
131 | phamacodynamics | 1 |
132 | physicians/practices | 1 |
133 | phytochemical/pharmacological | 1 |
134 | pittler | 1 |
135 | plasma-proteomics | 1 |
136 | pre-teens | 1 |
137 | prevention-has | 1 |
138 | prtoteinuria | 1 |
139 | qaly-scores | 1 |
140 | ragatz | 1 |
141 | rapid5 | 1 |
142 | registrant | 1 |
143 | rose-hips | 1 |
144 | scholtz | 1 |
145 | sculptors | 1 |
146 | sialoscintigraphy | 1 |
147 | siloxypentadienals | 1 |
148 | stecksen- | 1 |
149 | tetrabamate | 1 |
150 | tetramesityldigermene | 1 |
151 | thiomorpholine | 1 |
152 | trimetazidine-treatment | 1 |
153 | trimethoprim–sulfamethoxazole | 1 |
154 | undp/unfpa/world | 1 |
155 | usage-monitoring | 1 |
156 | ward-midwives | 1 |
1 | 1,4-diols | 1 |
2 | 1,8-diaminooctane | 1 |
3 | 1.49±0.59 | 1 |
4 | 10,242 | 2 |
5 | 115/261 | 1 |
6 | 13,339 | 1 |
7 | 14,677 | 1 |
8 | 15,740 | 1 |
9 | 2-naphthalenol | 2 |
10 | 4,4'-dichlorodiphenyltrichloroethane | 1 |
11 | 4,4-dimethylproline | 1 |
12 | 4,847 | 1 |
13 | 41,514 | 1 |
14 | 48/87 | 1 |
15 | 5-pyrimidinols | 2 |
16 | 56,603 | 1 |
17 | 58±7 | 2 |
18 | abciximam | 1 |
19 | administratively | 5 |
20 | ag-zp | 1 |
21 | al-ivm2 | 2 |
22 | ammionia | 1 |
23 | angiocholitis | 1 |
24 | ankaflavin | 12 |
25 | aph-4 | 8 |
26 | biatain-ag | 6 |
27 | bohu-tusyo-san | 4 |
28 | bp230 | 2 |
29 | brooks-gunn | 3 |
30 | c-coils | 1 |
31 | caldesmon | 7 |
32 | canalis | 1 |
33 | capabilities.measurements | 1 |
34 | carnidazol | 1 |
35 | caspsase-9 | 1 |
36 | cbhiix305 | 3 |
37 | celleagues | 1 |
38 | chrysoeriol-7-o-d-glucoside | 2 |
39 | cluster-analyses | 1 |
40 | co-publication | 1 |
41 | coccolithophores | 2 |
42 | communities.we | 1 |
43 | cpeb4 | 1 |
44 | d-methyl | 1 |
45 | dcers | 1 |
46 | dex-treatment | 2 |
47 | dimethylcrocetin | 2 |
48 | discariosi | 1 |
49 | donadio | 1 |
50 | dwarves | 1 |
51 | echolucencies | 2 |
52 | eligible.we | 1 |
53 | eventually | 1,246 |
54 | exretion | 1 |
55 | eyeshield | 2 |
56 | felony-level | 1 |
57 | fesses | 1 |
58 | finesrt | 2 |
59 | flexi | 1 |
60 | ga₂o₃ | 1 |
61 | gel² | 1 |
62 | gfp-cts1 | 4 |
63 | guenther | 1 |
64 | habituations | 1 |
65 | haemorperitoneum | 1 |
66 | herbal/botanical/supplements | 1 |
67 | higenamine | 4 |
68 | hit-to | 1 |
69 | hopefully | 239 |
70 | hydrae | 1 |
71 | hydroxycholoroquine | 1 |
72 | hypoxia-only | 1 |
73 | iiime | 2 |
74 | il‑8 | 3 |
75 | imprecision.we | 2 |
76 | incorporateself-management | 1 |
77 | irrationally | 4 |
78 | karyoplasts | 2 |
79 | kep10 | 4 |
80 | kitao | 5 |
81 | lagakos | 2 |
82 | laser-curettage/srp/laser-sealing | 1 |
83 | laughed | 4 |
84 | lg100268 | 4 |
85 | loss-framing | 1 |
86 | luminesce | 1 |
87 | lvht-patients | 1 |
88 | maleinization | 1 |
89 | mex-5 | 3 |
90 | milstein | 2 |
91 | mitogen/s | 1 |
92 | mokhada | 1 |
93 | mssa-negative | 1 |
94 | multivariately | 7 |
95 | mussaenoside | 3 |
96 | málek | 1 |
97 | nano-phytoplankton | 1 |
98 | nde2 | 2 |
99 | o-glycanase | 1 |
100 | onthe | 2 |
101 | owner/manager | 1 |
102 | p.ala1610ser | 2 |
103 | p38-nf-kb-sasp | 1 |
104 | paclitaxel-doxorubicin-cisplatin | 2 |
105 | parallelly | 7 |
106 | pbrm-1/baf180 | 2 |
107 | pcp-1 | 3 |
108 | pge-3521917-were | 1 |
109 | phamacodynamics | 1 |
110 | physicians/practices | 1 |
111 | phytochemical/pharmacological | 1 |
112 | pittler | 1 |
113 | plasma-proteomics | 1 |
114 | pre-teens | 1 |
115 | prevention-has | 1 |
116 | prtoteinuria | 1 |
117 | purob | 4 |
118 | pustulan | 2 |
119 | qaly-scores | 1 |
120 | r226q | 2 |
121 | ragatz | 1 |
122 | rapid5 | 1 |
123 | registrant | 1 |
124 | rf-coils | 2 |
125 | rose-hips | 1 |
126 | rtms-tdcs | 2 |
127 | schematically | 7 |
128 | scholtz | 1 |
129 | sculptors | 1 |
130 | secondarily | 260 |
131 | ser65→pro | 2 |
132 | shame-reduction | 2 |
133 | sialoscintigraphy | 1 |
134 | siloxypentadienals | 1 |
135 | someday | 5 |
136 | stecksen- | 1 |
137 | stenocardia | 3 |
138 | subsequently | 4,727 |
139 | tetrabamate | 1 |
140 | tetramesityldigermene | 1 |
141 | thereupon | 7 |
142 | thiomorpholine | 1 |
143 | trimetazidine-treatment | 1 |
144 | trimethoprim–sulfamethoxazole | 1 |
145 | ultimately | 1,755 |
146 | undercorrected | 5 |
147 | undp/unfpa/world | 1 |
148 | usage-monitoring | 1 |
149 | veronicaefolia | 4 |
150 | vinylarenes | 2 |
151 | viscolin | 7 |
152 | ward-midwives | 1 |
153 | wip1 | 5 |
154 | ws/mongolia/1/09 | 2 |
155 | x12b | 2 |
156 | yedz | 2 |
1 | stecksen- | 1 |
2 | kep10 | 4 |
3 | bp230 | 2 |
4 | 15,740 | 1 |
5 | pbrm-1/baf180 | 2 |
6 | pcp-1 | 3 |
7 | 115/261 | 1 |
8 | wip1 | 5 |
9 | gfp-cts1 | 4 |
10 | 10,242 | 2 |
11 | nde2 | 2 |
12 | al-ivm2 | 2 |
13 | 56,603 | 1 |
14 | aph-4 | 8 |
15 | 41,514 | 1 |
16 | cpeb4 | 1 |
17 | mex-5 | 3 |
18 | cbhiix305 | 3 |
19 | rapid5 | 1 |
20 | 4,847 | 1 |
21 | 14,677 | 1 |
22 | 48/87 | 1 |
23 | 58±7 | 2 |
24 | lg100268 | 4 |
25 | il‑8 | 3 |
26 | caspsase-9 | 1 |
27 | ws/mongolia/1/09 | 2 |
28 | 13,339 | 1 |
29 | 1.49±0.59 | 1 |
30 | mokhada | 1 |
31 | stenocardia | 3 |
32 | veronicaefolia | 4 |
33 | ammionia | 1 |
34 | prtoteinuria | 1 |
35 | x12b | 2 |
36 | purob | 4 |
37 | laughed | 4 |
38 | undercorrected | 5 |
39 | eyeshield | 2 |
40 | undp/unfpa/world | 1 |
41 | hydrae | 1 |
42 | luminesce | 1 |
43 | chrysoeriol-7-o-d-glucoside | 2 |
44 | mussaenoside | 3 |
45 | onthe | 2 |
46 | trimethoprim–sulfamethoxazole | 1 |
47 | iiime | 2 |
48 | 4,4'-dichlorodiphenyltrichloroethane | 1 |
49 | 1,8-diaminooctane | 1 |
50 | tetramesityldigermene | 1 |
51 | thiomorpholine | 1 |
52 | 4,4-dimethylproline | 1 |
53 | higenamine | 4 |
54 | hydroxycholoroquine | 1 |
55 | pge-3521917-were | 1 |
56 | o-glycanase | 1 |
57 | tetrabamate | 1 |
58 | mssa-negative | 1 |
59 | eligible.we | 1 |
60 | imprecision.we | 2 |
61 | communities.we | 1 |
62 | biatain-ag | 6 |
63 | laser-curettage/srp/laser-sealing | 1 |
64 | loss-framing | 1 |
65 | usage-monitoring | 1 |
66 | discariosi | 1 |
67 | flexi | 1 |
68 | málek | 1 |
69 | phytochemical/pharmacological | 1 |
70 | felony-level | 1 |
71 | 2-naphthalenol | 2 |
72 | carnidazol | 1 |
73 | d-methyl | 1 |
74 | abciximam | 1 |
75 | haemorperitoneum | 1 |
76 | pustulan | 2 |
77 | bohu-tusyo-san | 4 |
78 | milstein | 2 |
79 | viscolin | 7 |
80 | paclitaxel-doxorubicin-cisplatin | 2 |
81 | dimethylcrocetin | 2 |
82 | ankaflavin | 12 |
83 | brooks-gunn | 3 |
84 | co-publication | 1 |
85 | maleinization | 1 |
86 | shame-reduction | 2 |
87 | exretion | 1 |
88 | caldesmon | 7 |
89 | thereupon | 7 |
90 | nano-phytoplankton | 1 |
91 | kitao | 5 |
92 | donadio | 1 |
93 | ser65→pro | 2 |
94 | hit-to | 1 |
95 | p38-nf-kb-sasp | 1 |
96 | ag-zp | 1 |
97 | r226q | 2 |
98 | owner/manager | 1 |
99 | guenther | 1 |
100 | pittler | 1 |
101 | p.ala1610ser | 2 |
102 | mitogen/s | 1 |
103 | prevention-has | 1 |
104 | rtms-tdcs | 2 |
105 | phamacodynamics | 1 |
106 | plasma-proteomics | 1 |
107 | physicians/practices | 1 |
108 | echolucencies | 2 |
109 | vinylarenes | 2 |
110 | qaly-scores | 1 |
111 | coccolithophores | 2 |
112 | fesses | 1 |
113 | cluster-analyses | 1 |
114 | celleagues | 1 |
115 | ward-midwives | 1 |
116 | dwarves | 1 |
117 | canalis | 1 |
118 | angiocholitis | 1 |
119 | siloxypentadienals | 1 |
120 | c-coils | 1 |
121 | rf-coils | 2 |
122 | 1,4-diols | 1 |
123 | 5-pyrimidinols | 2 |
124 | pre-teens | 1 |
125 | habituations | 1 |
126 | lagakos | 2 |
127 | rose-hips | 1 |
128 | dcers | 1 |
129 | sculptors | 1 |
130 | lvht-patients | 1 |
131 | herbal/botanical/supplements | 1 |
132 | capabilities.measurements | 1 |
133 | karyoplasts | 2 |
134 | registrant | 1 |
135 | incorporateself-management | 1 |
136 | trimetazidine-treatment | 1 |
137 | dex-treatment | 2 |
138 | finesrt | 2 |
139 | someday | 5 |
140 | sialoscintigraphy | 1 |
141 | multivariately | 7 |
142 | ultimately | 1,755 |
143 | administratively | 5 |
144 | secondarily | 260 |
145 | schematically | 7 |
146 | irrationally | 4 |
147 | eventually | 1,246 |
148 | parallelly | 7 |
149 | hopefully | 239 |
150 | hypoxia-only | 1 |
151 | subsequently | 4,727 |
152 | yedz | 2 |
153 | ragatz | 1 |
154 | scholtz | 1 |
155 | ga₂o₃ | 1 |
156 | gel² | 1 |